PCVX NASDAQ
Credit Risk of going bust: lower than 79% of companies Debt: 1.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.08 (down 99.9%), Vaxcyte, Inc. would be worth roughly what it owes.
Total debt $115.4M against a stock market value of $9.44B.
Distance to default 9.39 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $57.7M (short-term plus half of long-term), stock volatility 53.6%; Altman Z'' 5.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
San Carlos, CA 94070
US
Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease and pneumonia. Beyond its flagship candidate, Vaxcyte is also advancing several other vaccine programs: VAX-XP, designed to offer protection against emergent bacterial strains and counter antimicrobial resistance; VAX-A1, a conjugate vaccine formulation aimed at Group A Streptococcus; and VAX-PG, a novel protein vaccine specifically developed to target the key pathogen responsible for periodontitis. The organization, which was initially established as SutroVax, Inc., officially rebranded as Vaxcyte, Inc. in May 2020. Founded in 2013, its corporate headquarters are situated in San Carlos, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Wassil Jim | S-Sale | 18,000 | $86.74 | 2026-10-05 |
| Cowan Elvia | M-Exempt | 19,000 | $25.92 | 2026-10-05 |
| Cowan Elvia | S-Sale | 19,000 | $86.74 | 2026-10-05 |
| Cowan Elvia | M-Exempt | 19,000 | $25.92 | 2026-10-05 |
| Wassil Jim | S-Sale | 2,155 | $56.65 | 2026-10-01 |